Skip to content

Bronchiectasis observational cohort and biobank UK study

Bronchiectasis multi-centre observational cohort and biobank UK study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17489966
Enrollment
2000
Registered
2017-07-28
Start date
2015-08-01
Completion date
Unknown
Last updated
2021-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults resident in the UK with bronchiectasis Respiratory Bronchiectasis

Interventions

This is an observational study. No interventions are undertaken as part of the study itself. Once consented, participants have data extraction undertaken from their clinical notes. T

Sponsors

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participant has capacity to provide written informed consent 2. Aged 18 years or over 3. Clinical and radiological diagnosis of bronchiectasis (documented) as defined by historical evidence of bronchiectasis on Computerised Tomographic (CT) scanning. Either CT or High resolution CT scanning (HRCT) is acceptable. 4. English speaking / access to interpreter (ability to complete quality of life questionnaires) 5. Exacerbation frequency – no lower threshold 6. Any suspected aetiological cause of bronchiectasis (except cystic fibrosis)

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment 2. Non-English speaking/ unable to access interpreter 3. Terminal illness not related to bronchiectasis 4. Aged <18 years 5. Bronchiectasis is not main or co-dominant respiratory disease 6. Lung transplantation for previous bronchiectasis 7. Inability to attend yearly clinical follow up

Design outcomes

Primary

MeasureTime frame
Develop and implement a cross sectional multi-centre observational cohort and biobank.

Secondary

MeasureTime frame
1. To evaluate and further define clinical outcomes longitudinally 2. To biobank serum and DNA from the cohort 3. To follow up entrants assessing mortality and morbidity

Countries

United Kingdom

Contacts

Public ContactPhil Mawson
Phil.Mawson@newcastle.ac.uk+44 (0)191 208 2422

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026